Thomas Woiwode Insider Trading $CRSP CRISPR Therapeutics AG

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Thomas Woiwode.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Thomas Woiwode. Thomas Woiwode is Director in Adverum Biotechnologies, Inc. ($AAVL) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Gritstone Oncology, Inc. ($GRTS) and Director in Passage BIO, Inc. ($PASG) and Director in Aligos Therapeutics, Inc. ($ALGS).

Thomas Woiwode in CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 641,014 shares
Current Value: $10,095,971
Latest Transaction: Jun 15 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Thomas Woiwode in CRISPR Therapeutics AG

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ADVM, ALGS, BOLD, CRSP, GRTS, PASG

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 15 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseA59.3130,0001,779,30030,000
Jun 15 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseA59.3130,0001,779,30030,000
May 17 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS58.731,00058,730640,014641 K to 640 K (-0.16 %)
May 17 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS57.9743,0002,492,710641,014684 K to 641 K (-6.29 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.451,65385,0475,6297.3 K to 5.6 K (-22.70 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.2658229,83390,73091.3 K to 90.7 K (-0.64 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.2624912,76438,77239 K to 38.8 K (-0.64 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.2622511,53434,97735.2 K to 35 K (-0.64 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.267,645391,8831,192,1391.2 M to 1.2 M (-0.64 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.317,424373,50191,31298.7 K to 91.3 K (-7.52 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.313,172159,58339,02142.2 K to 39 K (-7.52 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.312,862143,98735,20238.1 K to 35.2 K (-7.52 %)
May 09 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.3197,5504,907,7411,199,7841.3 M to 1.2 M (-7.52 %)
May 02 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.292,044102,79398,736100.8 K to 98.7 K (-2.03 %)
May 02 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.2687443,92742,19343.1 K to 42.2 K (-2.03 %)
May 02 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.2978839,62938,06438.9 K to 38.1 K (-2.03 %)
May 02 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.2926,8601,350,7891,297,3341.3 M to 1.3 M (-2.03 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0377938,973100,780101.6 K to 100.8 K (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0377938,973100,780101.6 K to 100.8 K (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0133316,65343,06743.4 K to 43.1 K (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0133316,65343,06743.4 K to 43.1 K (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0830015,02438,85239.2 K to 38.9 K (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0830015,02438,85239.2 K to 38.9 K (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0210,236512,0051,324,1941.3 M to 1.3 M (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.0210,236512,0051,324,1941.3 M to 1.3 M (-0.77 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.1114,086705,849101,559115.6 K to 101.6 K (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.1114,086705,849101,559115.6 K to 101.6 K (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.126,019301,67243,40049.4 K to 43.4 K (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.126,019301,67243,40049.4 K to 43.4 K (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.125,430272,15239,15244.6 K to 39.2 K (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.125,430272,15239,15244.6 K to 39.2 K (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.11185,0759,274,1081,334,4301.5 M to 1.3 M (-12.18 %)
Apr 30 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.11185,0759,274,1081,334,4301.5 M to 1.3 M (-12.18 %)
Apr 26 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.001,52877,928115,645117.2 K to 115.6 K (-1.30 %)
Apr 26 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.0065333,30349,41950.1 K to 49.4 K (-1.30 %)
Apr 26 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.6058929,80344,58245.2 K to 44.6 K (-1.30 %)
Apr 26 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.0020,0711,023,6211,519,5051.5 M to 1.5 M (-1.30 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.666,821345,552117,173124 K to 117.2 K (-5.50 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.002,915148,66550,07253 K to 50.1 K (-5.50 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS51.002,630134,13045,17147.8 K to 45.2 K (-5.50 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS50.6689,6284,540,5541,539,5761.6 M to 1.5 M (-5.50 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyJ0.002,32307,2825 K to 7.3 K (+46.84 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.0092,9180092.9 K to 0 (-100.00 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyJ0.0092,918092,9180 to 92.9 K
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.002,947013,27716.2 K to 13.3 K (-18.16 %)
Apr 24 2018CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.00497,05302,238,9792.7 M to 2.2 M (-18.17 %)
Dec 27 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS20.293,05962,0704,9598 K to 5 K (-38.15 %)
Nov 28 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS20.242004,0488,0188.2 K to 8 K (-2.43 %)
Nov 28 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellS20.211,70034,3588,2189.9 K to 8.2 K (-17.14 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyJ0.009,91809,9180 to 9.9 K
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.001,240001.2 K to 0 (-100.00 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyJ0.001,24001,2400 to 1.2 K
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.0017,2830017.3 K to 0 (-100.00 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyJ0.0017,283017,2830 to 17.3 K
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.00292,52900292.5 K to 0 (-100.00 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyJ0.00292,5290292,5290 to 292.5 K
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.0026,491052,98779.5 K to 53 K (-33.33 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.0061,9930123,994186 K to 124 K (-33.33 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.0023,899047,80171.7 K to 47.8 K (-33.33 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.00814,59901,629,2042.4 M to 1.6 M (-33.33 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.008,110016,22424.3 K to 16.2 K (-33.33 %)
Sep 07 2017CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorSellJ0.001,368,01302,736,0324.1 M to 2.7 M (-33.33 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.005,77400
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.0013,18000
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.005,21000
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.00173,16700
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.001,45400
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.00231,07700
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.0073,70400
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.00168,22400
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.0066,49000
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.002,210,41700
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.0019,52400
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.003,100,47700
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.002,75400
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseC0.00437,24700
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseA14.0030,000420,00060,000
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.005,774079,47873.7 K to 79.5 K (+7.83 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.0073,704073,7040 to 73.7 K
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyP14.004,58364,162185,987181.4 K to 186 K (+2.53 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.0013,1800181,404168.2 K to 181.4 K (+7.83 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.00168,2240168,2240 to 168.2 K
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.005,210071,70066.5 K to 71.7 K (+7.84 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.0066,490066,4900 to 66.5 K
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyP14.0060,219843,0662,443,8032.4 M to 2.4 M (+2.53 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.00173,16702,383,5842.2 M to 2.4 M (+7.83 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.002,210,41702,210,4170 to 2.2 M
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyP14.006028,42824,33423.7 K to 24.3 K (+2.54 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.001,454023,73222.3 K to 23.7 K (+6.53 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.0019,524022,2782.8 K to 22.3 K (+708.93 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.002,75402,7540 to 2.8 K
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyP14.0095,5961,338,3444,104,0454 M to 4.1 M (+2.38 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.00231,07704,008,4493.8 M to 4 M (+6.12 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.003,100,47703,777,372676.9 K to 3.8 M (+458.04 %)
Dec 23 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorBuyC0.00437,2470676,895239.6 K to 676.9 K (+182.45 %)
Oct 20 2016CRSPCRISPR Therapeutic ...Woiwode ThomasDirectorOption ExerciseA14.0030,000420,00030,000

Page:   1